Tildrakizumab: interpreting the data

Linked Article: Thaçi et al. Br J Dermatol 2021; 185:323–334.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2021-08, Vol.185 (2), p.242-243
Hauptverfasser:	Purvis, C.G., Emmerich, V.K., Feldman, S.R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Monoclonal antibodies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	243
container_issue	2
container_start_page	242
container_title	British journal of dermatology (1951)
container_volume	185
creator	Purvis, C.G. Emmerich, V.K. Feldman, S.R.
description	Linked Article: Thaçi et al. Br J Dermatol 2021; 185:323–334.
doi_str_mv	10.1111/bjd.20430
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2532244617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2532244617</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2900-170dda048fc33afe39da5f43a01d23ec9d59f3532005f44d42719e4699e40eef3</originalsourceid><addsrcrecordid>eNp10E1PwzAMBuAIgcQYHPgHk-AAh25OnLaEGxvfmsRlnKOscaCja0fSCo1fT6CckMjBkazHlvUydsxhzOObLFd2LEAi7LABxyxNBEfcZQMAyBNQGe6zgxBWABwhhQE7XZSV9eat_OzWZnk5KuuW_MZTW9Yvo_aVRta05pDtOVMFOvr9h-z59mYxu0_mT3cPs6t5UggFkPAcrDUgL1yBaByhsiZ1Eg1wK5AKZVPlMEUBENvSSpFzRTJTsQCRwyE76_dufPPeUWj1ugwFVZWpqemCFnFWSJnxPNKTP3TVdL6O10WVcQmpynhU570qfBOCJ6c3vlwbv9Uc9HdeOualf_KKdtLbj7Ki7f9QTx-v-4kvXUppPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561405961</pqid></control><display><type>article</type><title>Tildrakizumab: interpreting the data</title><source>Wiley Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Purvis, C.G. ; Emmerich, V.K. ; Feldman, S.R.</creator><creatorcontrib>Purvis, C.G. ; Emmerich, V.K. ; Feldman, S.R.</creatorcontrib><description>Linked Article: Thaçi et al. Br J Dermatol 2021; 185:323–334.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/bjd.20430</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Monoclonal antibodies</subject><ispartof>British journal of dermatology (1951), 2021-08, Vol.185 (2), p.242-243</ispartof><rights>2021 British Association of Dermatologists</rights><rights>Copyright © 2021 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2900-170dda048fc33afe39da5f43a01d23ec9d59f3532005f44d42719e4699e40eef3</cites><orcidid>0000-0002-8145-6477 ; 0000-0003-4996-4751 ; 0000-0002-0090-6289</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjd.20430$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjd.20430$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Purvis, C.G.</creatorcontrib><creatorcontrib>Emmerich, V.K.</creatorcontrib><creatorcontrib>Feldman, S.R.</creatorcontrib><title>Tildrakizumab: interpreting the data</title><title>British journal of dermatology (1951)</title><description>Linked Article: Thaçi et al. Br J Dermatol 2021; 185:323–334.</description><subject>Monoclonal antibodies</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp10E1PwzAMBuAIgcQYHPgHk-AAh25OnLaEGxvfmsRlnKOscaCja0fSCo1fT6CckMjBkazHlvUydsxhzOObLFd2LEAi7LABxyxNBEfcZQMAyBNQGe6zgxBWABwhhQE7XZSV9eat_OzWZnk5KuuW_MZTW9Yvo_aVRta05pDtOVMFOvr9h-z59mYxu0_mT3cPs6t5UggFkPAcrDUgL1yBaByhsiZ1Eg1wK5AKZVPlMEUBENvSSpFzRTJTsQCRwyE76_dufPPeUWj1ugwFVZWpqemCFnFWSJnxPNKTP3TVdL6O10WVcQmpynhU570qfBOCJ6c3vlwbv9Uc9HdeOualf_KKdtLbj7Ki7f9QTx-v-4kvXUppPA</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Purvis, C.G.</creator><creator>Emmerich, V.K.</creator><creator>Feldman, S.R.</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8145-6477</orcidid><orcidid>https://orcid.org/0000-0003-4996-4751</orcidid><orcidid>https://orcid.org/0000-0002-0090-6289</orcidid></search><sort><creationdate>202108</creationdate><title>Tildrakizumab: interpreting the data</title><author>Purvis, C.G. ; Emmerich, V.K. ; Feldman, S.R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2900-170dda048fc33afe39da5f43a01d23ec9d59f3532005f44d42719e4699e40eef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Monoclonal antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Purvis, C.G.</creatorcontrib><creatorcontrib>Emmerich, V.K.</creatorcontrib><creatorcontrib>Feldman, S.R.</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Purvis, C.G.</au><au>Emmerich, V.K.</au><au>Feldman, S.R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tildrakizumab: interpreting the data</atitle><jtitle>British journal of dermatology (1951)</jtitle><date>2021-08</date><risdate>2021</risdate><volume>185</volume><issue>2</issue><spage>242</spage><epage>243</epage><pages>242-243</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><abstract>Linked Article: Thaçi et al. Br J Dermatol 2021; 185:323–334.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><doi>10.1111/bjd.20430</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-8145-6477</orcidid><orcidid>https://orcid.org/0000-0003-4996-4751</orcidid><orcidid>https://orcid.org/0000-0002-0090-6289</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 0007-0963
ispartof	British journal of dermatology (1951), 2021-08, Vol.185 (2), p.242-243
issn	0007-0963 1365-2133
language	eng
recordid	cdi_proquest_miscellaneous_2532244617
source	Wiley Journals; Oxford University Press Journals All Titles (1996-Current)
subjects	Monoclonal antibodies
title	Tildrakizumab: interpreting the data
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A46%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tildrakizumab:%20interpreting%20the%20data&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Purvis,%20C.G.&rft.date=2021-08&rft.volume=185&rft.issue=2&rft.spage=242&rft.epage=243&rft.pages=242-243&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/bjd.20430&rft_dat=%3Cproquest_cross%3E2532244617%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2561405961&rft_id=info:pmid/&rfr_iscdi=true